Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,800
Closed -$1.41M 913
2023
Q4
$1.41M Buy
+19,800
New +$1.38M 0.05% 342
2023
Q1
Sell
-25,800
Closed -$1.93M 844
2022
Q4
$1.93M Buy
+25,800
New +$1.84M 0.09% 232
2021
Q2
Sell
-10,700
Closed -$796K 1990
2021
Q1
$796K Buy
+10,700
New +$812K 0.02% 820
2017
Q4
Sell
-26,300
Closed -$965K 2059
2017
Q3
$965K Buy
+26,300
New +$1.06M 0.01% 1188
2017
Q1
Sell
-16,000
Closed -$642K 2080
2016
Q4
$642K Hold
16,000
0.01% 1406
2016
Q3
$621K Hold
16,000
0.01% 1293
2016
Q2
$554K Buy
+16,000
New +$554K 0.01% 1489

Other funds holding HOLX

Paloma Partners's HOLX Position: Q4 2024 in Review

Paloma Partners sold out of Hologic (HOLX) in Q4 2024, closing a stake of 7,145 shares — an estimated $582K sold.

Paloma Partners first reported a position in HOLX in Q1 2014 and held it in 30 quarters. The position peaked at $5.85M in Q4 2018. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Paloma Partners reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 7,145 Hologic shares in Q4 2024, an estimated $582K.
  • Paloma Partners first reported a position in Hologic in Q1 2014 and held it in 30 quarters.
  • Paloma Partners's Hologic position peaked at $5.85M in Q4 2018.
  • 719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.